These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19008314)

  • 1. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells.
    Wang SH; Chen GH; Fan Y; Van Antwerp M; Baker JR
    Endocrinology; 2009 Apr; 150(4):2000-7. PubMed ID: 19008314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis.
    Gangi E; Vasu C; Cheatem D; Prabhakar BS
    J Immunol; 2005 Jun; 174(11):7006-13. PubMed ID: 15905543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis.
    Vasu C; Dogan RN; Holterman MJ; Prabhakar BS
    J Immunol; 2003 Jun; 170(11):5511-22. PubMed ID: 12759428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen.
    Morris GP; Brown NK; Kong YC
    J Autoimmun; 2009 Aug; 33(1):68-76. PubMed ID: 19375891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
    Morris GP; Kong YC
    J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.
    Ganesh BB; Cheatem DM; Sheng JR; Vasu C; Prabhakar BS
    Int Immunol; 2009 Mar; 21(3):269-82. PubMed ID: 19174473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
    J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells.
    Verginis P; Li HS; Carayanniotis G
    J Immunol; 2005 Jun; 174(11):7433-9. PubMed ID: 15905592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis.
    Fang Y; Sharp GC; Yagita H; Braley-Mullen H
    J Pathol; 2008 Dec; 216(4):505-13. PubMed ID: 18810759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis.
    Diao Z; Shi J; Zhu J; Yuan H; Ru Q; Liu S; Liu Y; Zheng D
    Cancer Immunol Immunother; 2013 Apr; 62(4):653-63. PubMed ID: 23143747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.
    Larmonier N; Marron M; Zeng Y; Cantrell J; Romanoski A; Sepassi M; Thompson S; Chen X; Andreansky S; Katsanis E
    Cancer Immunol Immunother; 2007 Jan; 56(1):48-59. PubMed ID: 16612596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.
    Flynn JC; Meroueh C; Snower DP; David CS; Kong YM
    Clin Exp Immunol; 2007 Mar; 147(3):547-54. PubMed ID: 17302906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
    Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
    Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis.
    Morris GP; Yan Y; David CS; Kong YC
    J Immunol; 2005 Mar; 174(5):3111-6. PubMed ID: 15728527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice.
    Zhu X; Wang M; Crump CH; Mishra A
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G550-8. PubMed ID: 19571233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CD4
    Khantakova J; Tereshchenko V; Kurilin V; Silkov A; Maksyutov A; Lopatnikova J; Shevchenko J; Knauer N; Kulikova E; Sennikov S
    J Interferon Cytokine Res; 2019 Sep; 39(9):531-538. PubMed ID: 31070504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of regulatory T cell number in hepatocellular carcinoma-bearing mice and its relationship with tumor growth].
    Zhang P; Zhang LN; Zhu FL; Wang Q; Wang XY; Li HY; Liu CM; Gao F; Liu CH
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):342-5. PubMed ID: 17892128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.